MA Private Wealth’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $320K | Buy |
1,273
+116
| +10% | +$25K | 0.05% | 78 |
|
|
2026
Q1 | $252K | Buy |
1,157
+13
| +1% | +$2.88K | 0.04% | 80 |
|
|
2025
Q4 | $261K | Sell |
1,144
-3
| -0.3% | -$683 | 0.04% | 78 |
|
|
2025
Q3 | $266K | Buy |
+1,147
| New | +$234K | 0.04% | 75 |
|
|
2025
Q2 | – | Sell |
-1,053
| Closed | -$221K | – | 81 |
|
|
2025
Q1 | $221K | Buy |
+1,053
| New | +$205K | 0.04% | 73 |
|
|
2024
Q4 | – | Sell |
-2,246
| Closed | -$444K | – | 73 |
|
|
2024
Q3 | $444K | Buy |
2,246
+201
| +10% | +$37.5K | 0.08% | 56 |
|
|
2024
Q2 | $351K | Hold |
2,045
| – | – | 0.07% | 62 |
|
|
2024
Q1 | $372K | Sell |
2,045
-598
| -23% | -$103K | 0.08% | 53 |
|
|
2023
Q4 | $410K | Sell |
2,643
-755
| -22% | -$110K | 0.09% | 58 |
|
|
2023
Q3 | $507K | Sell |
3,398
-1
| -0% | -$147 | 0.12% | 51 |
|
|
2023
Q2 | $458K | Sell |
3,399
-1
| -0% | -$147 | 0.11% | 56 |
|
|
2023
Q1 | $542K | Hold |
3,400
| – | – | 0.13% | 48 |
|
|
2022
Q4 | $549K | Hold |
3,400
| – | – | 0.13% | 53 |
|
|
2022
Q3 | $513K | Hold |
3,400
| – | – | 0.13% | 49 |
|
|
2022
Q2 | $517K | Sell |
3,400
-38
| -1% | -$5.81K | 0.13% | 51 |
|
|
2022
Q1 | $557K | Buy |
3,438
+10
| +0.3% | +$1.45K | 0.1% | 56 |
|
|
2021
Q4 | $464K | Buy |
3,428
+30
| +0.9% | +$3.54K | 0.08% | 63 |
|
|
2021
Q3 | $367K | Buy |
3,398
+31
| +0.9% | +$3.54K | 0.07% | 68 |
|
|
2021
Q2 | $379K | Buy |
3,367
+30
| +0.9% | +$3.38K | 0.08% | 70 |
|
|
2021
Q1 | $361K | Buy |
3,337
+33
| +1% | +$3.53K | 0.08% | 70 |
|
|
2020
Q4 | $354K | Sell |
3,304
-169
| -5% | -$16.2K | 0.08% | 56 |
|
|
2020
Q3 | $304K | Buy |
3,473
+32
| +0.9% | +$3.01K | 0.07% | 68 |
|
|
2020
Q2 | $338K | Buy |
3,441
+34
| +1% | +$2.99K | 0.08% | 62 |
|
|
2020
Q1 | $260K | Sell |
3,407
-32
| -0.9% | -$2.73K | 0.08% | 68 |
|
|
2019
Q4 | $304K | Sell |
3,439
-283
| -8% | -$23.5K | 0.09% | 56 |
|
|
2019
Q3 | $282K | Sell |
3,722
-1,779
| -32% | -$122K | 0.08% | 70 |
|
|
2019
Q2 | $400K | Sell |
5,501
-129
| -2% | -$10.1K | 0.12% | 62 |
|
|
2019
Q1 | $454K | Sell |
5,630
-699
| -11% | -$57.2K | 0.14% | 61 |
|
|
2018
Q4 | $583K | Buy |
+6,329
| New | +$557K | 0.22% | 58 |
|
Other funds holding ABBV
MA Private Wealth's ABBV Position: Q2 2026 in Review
MA Private Wealth increased its AbbVie (ABBV) stake by 10% in Q2 2026, buying an estimated $25K and bringing the position to 1,273 shares worth $320K. The position accounts for 0.05% of the portfolio, ranked #78.
MA Private Wealth first reported a position in ABBV in Q4 2018 and has held it in 29 quarters since. The position peaked at $583K in Q4 2018. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- MA Private Wealth held 1,273 shares of AbbVie worth $320K as of Q2 2026.
- MA Private Wealth bought 116 AbbVie shares in Q2 2026, an estimated $25K.
- AbbVie made up 0.05% of MA Private Wealth's portfolio in Q2 2026, its #78 holding.
- MA Private Wealth first reported a position in AbbVie in Q4 2018 and has held it in 29 quarters since.
- MA Private Wealth's AbbVie position peaked at $583K in Q4 2018.
- 4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on MA Private Wealth's 13F filing for Q2 2026, filed 28 Jul 2026.